News
Jon Walsh, founder, chief scientific officer, Unlearn, explains how AI and digital twin technologies are being applied to improve data transparency, ensure reproducibility, and strengthen the ...
Results from a Phase II trial (NCT06640972) showed that patients treated with RDX-002 experienced significant reductions in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback